Cromolyn sodium 4 % Ophthalmic Solution
RxNorm 831109
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 831109 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cromolyn sodium 4 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Cromolyn sodium 40 mg/ML Ophthalmic Solution
(Atom ID: 12342861)
PSNPrescribable
Prescribable Name (PSN):
Cromolyn sodium 4 % Ophthalmic Solution
(Atom ID: 6398238)
SYPrescribable
Synonym (SY):
Cromolyn sodium 4 % Ophthalmic Solution
(Atom ID: 3754707)
PTPrescribable
Designated preferred name (PT):
Cromolyn sodium 40 mg/mL eye solution
(Atom ID: 11436121)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely cromoglicate sodium 40 mg/1 mL conventional release eye solution (clinical drug)
(Atom ID: 11439632)
SYPrescribable
Synonym (SY):
Sodium cromoglicate 40 mg/mL eye solution
(Atom ID: 11441283)
Patient Education
Cromolyn Ophthalmic
Cromolyn ophthalmic is used to treat the symptoms of allergic conjunctivitis (a condition in which the eyes become itchy, swollen, red, and teary when they are exposed to certain substances) and keratitis (a condition that causes swelling of the cornea [tissue in the front of the eye] that causes eye redness, pain, and tearing and changes in vision) in adults and children 4 years of age and older. Cromolyn is in a class of medications called mast cell stabilizers. It works by preventing the release of substances that cause inflammation (swelling) of the eyes.
[Learn More]
* Please review the disclaimer below.